Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Polypid Ltd.

Clinical trials sponsored by Polypid Ltd., explained in plain language.

PolyPid Ltd. PYPD NASDAQ

Biopharma developing controlled-release drug delivery systems for surgical infections.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 4 Terminated 1

New antibiotic coating could shield heart surgery patients from dangerous infections

Prevention Terminated

This trial tests whether D-PLEX, an extended-release form of the antibiotic doxycycline, can prevent sternal wound infections in people at high risk after cardiac surgery. Participants receive D-PLEX along with standard intravenous antibiotics, or standard antibiotics alone. The …

Phase: PHASE3 • Sponsor: PolyPid Ltd. • Aim: Prevention

Last updated Jul 02, 2026 00:00 UTC